These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
972 related items for PubMed ID: 15494706
21. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Frick B, Schroecksnadel K, Neurauter G, Leblhuber F, Fuchs D. Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611 [Abstract] [Full Text] [Related]
22. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. Cozzi A, Zignego AL, Carpendo R, Biagiotti T, Aldinucci A, Monti M, Giannini C, Rosselli M, Laffi G, Moroni F. J Viral Hepat; 2006 Jun; 13(6):402-8. PubMed ID: 16842443 [Abstract] [Full Text] [Related]
23. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M. J Clin Psychopharmacol; 2002 Feb; 22(1):86-90. PubMed ID: 11799348 [Abstract] [Full Text] [Related]
24. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients. Kato A, Suzuki Y, Suda T, Suzuki M, Fujie M, Takita T, Furuhashi M, Maruyama Y, Chida K, Hishida A. Hemodial Int; 2010 Oct; 14(4):418-24. PubMed ID: 20673309 [Abstract] [Full Text] [Related]
25. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Mol Psychiatry; 2002 Oct; 7(5):468-73. PubMed ID: 12082564 [Abstract] [Full Text] [Related]
26. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? Quak J, Doornbos B, Roest AM, Duivis HE, Vogelzangs N, Nolen WA, Penninx BW, Kema IP, de Jonge P. Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191 [Abstract] [Full Text] [Related]
27. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin. Pawlowski T, Pawlak D, Inglot M, Zalewska M, Marciniak D, Bugajska J, Janocha-Litwin J, Malyszczak K. J Psychiatry Neurosci; 2021 Jan 18; 46(1):E166-E175. PubMed ID: 33464780 [Abstract] [Full Text] [Related]
28. Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects. Bannink M, Fekkes D, Van Gool AR, Kruit WH, Sleijfer S, van der Holt B, Eggermont AM, Stoter G, Hengeveld MW. Neuropsychobiology; 2007 Jan 18; 55(3-4):225-31. PubMed ID: 17873497 [Abstract] [Full Text] [Related]
29. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Pertovaara M, Raitala A, Lehtimäki T, Karhunen PJ, Oja SS, Jylhä M, Hervonen A, Hurme M. Mech Ageing Dev; 2006 May 18; 127(5):497-9. PubMed ID: 16513157 [Abstract] [Full Text] [Related]
30. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C. Galvão-de Almeida A, Quarantini LC, Sampaio AS, Lyra AC, Parise CL, Paraná R, de Oliveira IR, Koenen KC, Miranda-Scippa A, Guindalini C. Brain Behav Immun; 2011 Oct 18; 25(7):1491-7. PubMed ID: 21693183 [Abstract] [Full Text] [Related]
31. Indoleamine 2,3-dioxygenase in lung allograft tolerance. Meloni F, Giuliano S, Solari N, Draghi P, Miserere S, Bardoni AM, Salvini R, Bini F, Fietta AM. J Heart Lung Transplant; 2009 Nov 18; 28(11):1185-92. PubMed ID: 19783182 [Abstract] [Full Text] [Related]
32. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats. Kanth VR, Lavanya K, Srinivas J, Raju TN. Curr Eye Res; 2009 Apr 18; 34(4):274-81. PubMed ID: 19373575 [Abstract] [Full Text] [Related]
34. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. Stress; 2008 May 18; 11(3):198-209. PubMed ID: 18465467 [Abstract] [Full Text] [Related]
35. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K, Margreiter R, Fuchs D, Weiss HG. Obes Surg; 2006 May 18; 16(5):541-8. PubMed ID: 16687019 [Abstract] [Full Text] [Related]
36. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome. Pertovaara M, Raitala A, Uusitalo H, Pukander J, Helin H, Oja SS, Hurme M. Clin Exp Immunol; 2005 Oct 18; 142(1):155-61. PubMed ID: 16178870 [Abstract] [Full Text] [Related]
37. Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms. Teshigawara T, Mouri A, Kubo H, Nakamura Y, Shiino T, Okada T, Morikawa M, Nabeshima T, Ozaki N, Yamamoto Y, Saito K. J Affect Disord; 2019 Aug 01; 255():168-176. PubMed ID: 31158779 [Abstract] [Full Text] [Related]
38. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Connor TJ, Starr N, O'Sullivan JB, Harkin A. Neurosci Lett; 2008 Aug 15; 441(1):29-34. PubMed ID: 18584961 [Abstract] [Full Text] [Related]
39. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Capuron L, Ravaud A, Miller AH, Dantzer R. Brain Behav Immun; 2004 May 15; 18(3):205-13. PubMed ID: 15050647 [Abstract] [Full Text] [Related]
40. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo. Iwamoto N, Ito H, Ando K, Ishikawa T, Hara A, Taguchi A, Saito K, Takemura M, Imawari M, Moriwaki H, Seishima M. Liver Int; 2009 Feb 15; 29(2):277-83. PubMed ID: 18397228 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]